retatrutide clinical trials update Phase 3: TRIUMPH Program Results 2026 Retatrutide Side Effects Research |

Enhanced insulin sensitivity can reduce the risk of metabolic syndromea combination of high blood pressure, high blood sugar, and abnormal cholesterol levels that increases the risk of heart disease

But here is what makes retatrutide dosing particularly important

Evidence from SURPASS CVOT is awaited to assess whether these benefits on surrogate markers will translate into actual MACE prevention

10.1 Future therapeutic effects As advancements continue and overcome current gaps, GLP1-RAs are expected to become a drug of choice as a monotherapy or as combination therapy for a wide range of diseases

Preclinical studies have clearly demonstrated that GLP-1RAs effectively reduce hepatic macrophage infiltration and suppress expression of TNF- , IL-6, and other pro-inflammatory mediators in animal models of MASLD (21, 22)

Check the manufacturer site at the time of fill for current terms